Clifford Robinson, MD
Enriched profileProfessor of Radiation Oncology, Chief of Stereotactic Body Radiation Therapy, and Associate Director of Clinical Programs at Washington University School of Medicine in St. Louis · Washington University School of Medicine in St. Louis
Clifford Robinson is Professor of Radiation Oncology, Chief of Stereotactic Body Radiation Therapy, and Associate Director of Clinical Programs at Washington University School of Medicine in St. Louis at Washington University School of Medicine in St. Louis. OpenAlex indexes 585 publications with 16,530 citations (h-index 58); ClinicalTrials.gov lists 5 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Radiation Oncology profiles in the findmyKOL directory.
Data verified 18 Oct 2026
Overview
Updated 23 Oct 2026
Clifford Robinson, MD, is Professor of Radiation Oncology, Chief of Stereotactic Body Radiation Therapy, and Associate Director of Clinical Programs at Washington University School of Medicine in St. Louis. The public record shows 585 publications with 16,530 citations (h-index 58), centered on Advanced Radiotherapy Techniques, Lung Cancer Diagnosis and Treatment, Lung Cancer Treatments and Mutations. It also documents an investigator role on 5 registered clinical trials, industry payments reported by 7 companies, 4 NIH-funded awards (2017–2026).
- Most recent indexed publication: 2026 · Journal of clinical oncology
- Top research focus: Advanced Radiotherapy Techniques
- 5 registered trials on ClinicalTrials.gov
- Open Payments reporting from 7 companies
Generated from the cited public record · current as of 23 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 17 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 186.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 23 Oct 2026
Listed as an investigator on 5 registered studies on ClinicalTrials.gov. The most recent:
- Pilot Study of Same-session MR-only Simulation and Treatment With Stereotactic MRI-guided Adaptive Radiotherapy (SMART) for Oligometastases of the Spine
Sponsor: Washington University School of Medicine
- Dual-Energy CT on Plan Quality, Dose-delivery Accuracy, and Simulated Outcomes of Patients Treated With Proton or Photon Therapy
Sponsor: Washington University School of Medicine
- MRI-Guided Stereotactic Body Radiation Therapy (SBRT) for Ovarian Cancer
Sponsor: Washington University School of Medicine
Industry payments
Updated 23 Oct 2026
7 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Siemens Medical Solutions USA, Inc.Program year20256 payments$46,566openpaymentsdata.cms.gov ↗
- Janssen Research & Development, LLCProgram year20252 payments
- EmpNia, Inc.Program year20251 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
57.9%Opioid Agonist57.9%Oxycodone Hcl61%Oxycontin39%Part D<11 patientsRespiratory
42.1%Opioid Agonist42.1%Hydrocodone-Acetaminophen100%Part D≥11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 23 Oct 2026
4 NIH research awards on record, funded 2017–2026 per NIH RePORTER. The latest:
- WASHINGTON UNIVERSITY / SITEMAN CANCER CENTER LEAD ACADEMIC SITE
Washington University
FY2026$2,071,012UG1CA233339 - Washington University (WU) ROBIN Center: MicroEnvironment and Tumor Effects Of Radiotherapy (METEOR)
Washington University
FY2026$1,533,522U54CA274318 - Comparative Effectiveness of Surgery vs Stereotactic Radiation Therapy for Stage I Lung Cancer
Washington University
FY2026$577,595R01CA258681
Congress activity
Updated 23 Oct 2026
178 congress contributions (2003–2026) across AACR, ASCO, ASTRO, ESMO per OpenAlex. The most recent:
- Can Simulation CTs be Used to Identify and Intervene on Incidental Coronary Artery Disease in Patients with Breast Cancer?
ASTRO Annual Meeting
ASTRO2025Co-author - Examining the Effects of Whole Brain Radiation Therapy and Stereotactic Radiosurgery on Brain Aging by Surface-Based Deep Learning
ASTRO Annual Meeting
ASTRO2025Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 23 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Long-Term Analysis of NRG Oncology RTOG 0539: A Phase II Trial of Observation for Low-Risk Meningioma and Radiotherapy for Intermediate- and High-Risk Meningioma.
Journal of clinical oncology
Clinical Trial2026 - Variability and Main Determinants of Planning Target Volume During Cardiac Stereotactic Radioablation for Refractory Ventricular Arrhythmias: A Systematic Review and Pooled Analysis.
Journal of cardiovascular electrophysiology
Article2026 - Early ctDNA Stratifies Survival in Locally Advanced and Oligometastatic Lung Cancer Treated with Radiotherapy.
Clinical cancer research
Clinical Trial2026 - Radiation Oncology-Biology Integration Network: Bridging the Gap between Biological Research and Clinical Practice.
Clinical cancer research
Review2026
Most-cited works
by citation count (OpenAlex)- 02
- 03
- 04Noninvasive Cardiac Radiation for Ablation of Ventricular TachycardiaArticle662 citations2017
- 05
Network
Updated 23 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 23 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Other
profiles.wustl.edu/en/persons/clifford-robinson
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.wustl.edu ↗
Mentions by others
where others cite or feature them- Facebook
facebook.com/SitemanCancerCenter/posts/10155855808866412
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →facebook.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 23 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →radonc.wustl.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →radonc.wustl.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →radonc.wustl.edu ↗
Editorial & leadership roles
journal and society appointments- Board of Directors
Nominating Committee Academic Physician, American Society for Radiation Oncology
2025verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →source.washu.edu ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →source.washu.edu ↗
- National Chair
Lung Cancer Committee, American Board of Radiology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →faculty.med.wustl.edu ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →radonc.wustl.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →radonc.wustl.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →radonc.wustl.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →radonc.wustl.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →radonc.wustl.edu ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →radonc.wustl.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Ramaswamy Govindan, MD
Washington University School of Medicine in St. Louis
Marin Kollef, MD
Washington University School of Medicine in St. Louis
Mark Huffman, MD
Washington University School of Medicine in St. Louis
Ravi Vij, MD
Washington University School of Medicine in St. Louis
Pasi Janne, MD, PhD
Dana-Farber Cancer Institute
Julie Brahmer, MD
Johns Hopkins University School of Medicine
Enriqueta Felip, MD, PhD
Vall d'Hebron Institute of Oncology (VHIO)
Funda Meric-Bernstam, MD
The University of Texas MD Anderson Cancer Center